Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

We conducted a study to assess the effect of rosuvastatin use on fibrinolysis in patients with previous venous thromboembolism (VTE). This was a post hoc analysis within the STAtins Reduce Thrombophilia (START) study (NCT01613794). Plasma fibrinolytic potential, fibrinogen, plasmin inhibitor, plasmi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schol‐Gelok, Suzanne, de Maat, Moniek P. M., Biedermann, Joseph S., van Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., van der Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Platelets Haemostasis and Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539918/
https://www.ncbi.nlm.nih.gov/pubmed/32301122
http://dx.doi.org/10.1111/bjh.16648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539918/
https://www.ncbi.nlm.nih.gov/pubmed/32301122
http://dx.doi.org/10.1111/bjh.16648

Ejemplares similares